Khaitov M R, Laza-Stanca V, Edwards M R, Walton R P, Rohde G, Contoli M, Papi A, Stanciu L A, Kotenko S V, Johnston S L
Department of Respiratory Medicine, National Heart and Lung Institute, Wright Fleming Institute of Infection and Immunity and MRC and Asthma UK Centre in Allergic Mechanisms of Asthma, Imperial College London, Norfolk Place, London, UK.
Allergy. 2009 Mar;64(3):375-86. doi: 10.1111/j.1398-9995.2008.01826.x. Epub 2009 Jan 28.
Respiratory viruses, predominantly rhinoviruses are the major cause of asthma exacerbations. Impaired production of interferon-beta in rhinovirus infected bronchial epithelial cells (BECs) and of the newly discovered interferon-lambdas in both BECs and bronchoalveolar lavage cells, is implicated in asthma exacerbation pathogenesis. Thus replacement of deficient interferon is a candidate new therapy for asthma exacerbations. Rhinoviruses and other respiratory viruses infect both BECs and macrophages, but their relative capacities for alpha-, beta- and lambda-interferon production are unknown.
To provide guidance regarding which interferon type is the best candidate for development for treatment/prevention of asthma exacerbations we investigated respiratory virus induction of alpha-, beta- and lambda-interferons in BECs and peripheral blood mononuclear cells (PBMCs) by reverse transferase-polymerase chain reaction and enzyme-linked immunosorbent assay.
Rhinovirus infection of BEAS-2B BECs induced interferon-alpha mRNA expression transiently at 8 h and interferon-beta later at 24 h while induction of interferon-lambda was strongly induced at both time points. At 24 h, interferon-alpha protein was not detected, interferon-beta was weakly induced while interferon-lambda was strongly induced. Similar patterns of mRNA induction were observed in primary BECs, in response to both rhinovirus and influenza A virus infection, though protein levels were below assay detection limits. In PBMCs interferon-alpha, interferon-beta and interferon-lambda mRNAs were all strongly induced by rhinovirus at both 8 and 24 h and proteins were induced: interferon-alpha>-beta>-lambda. Thus respiratory viruses induced expression of alpha-, beta- and lambda-interferons in BECs and PBMCs. In PBMCs interferon-alpha>-beta>-lambda while in BECs, interferon-lambda>-beta>-alpha.
We conclude that interferon-lambdas are likely the principal interferons produced during innate responses to respiratory viruses in BECs and interferon-alphas in PBMCs, while interferon-beta is produced by both cell types.
呼吸道病毒,主要是鼻病毒,是哮喘急性加重的主要原因。鼻病毒感染的支气管上皮细胞(BECs)中β干扰素产生受损,以及新发现的BECs和支气管肺泡灌洗细胞中的λ干扰素产生受损,与哮喘急性加重的发病机制有关。因此,补充缺乏的干扰素是哮喘急性加重的一种潜在新疗法。鼻病毒和其他呼吸道病毒可感染BECs和巨噬细胞,但它们产生α、β和λ干扰素的相对能力尚不清楚。
为了确定哪种类型的干扰素最适合开发用于治疗/预防哮喘急性加重,我们通过逆转录聚合酶链反应和酶联免疫吸附测定法,研究了呼吸道病毒在BECs和外周血单核细胞(PBMCs)中诱导α、β和λ干扰素的情况。
鼻病毒感染BEAS-2B BECs后,在8小时短暂诱导干扰素-α mRNA表达,24小时后诱导干扰素-β表达,而在两个时间点均强烈诱导干扰素-λ表达。在24小时时,未检测到干扰素-α蛋白,干扰素-β诱导较弱,而干扰素-λ诱导强烈。在原代BECs中,对鼻病毒和甲型流感病毒感染的反应也观察到类似的mRNA诱导模式,尽管蛋白水平低于检测限。在PBMCs中,鼻病毒在8小时和24小时均强烈诱导干扰素-α、干扰素-β和干扰素-λ mRNA表达,并诱导蛋白表达:干扰素-α>β>λ。因此,呼吸道病毒在BECs和PBMCs中诱导α、β和λ干扰素表达。在PBMCs中,干扰素-α>β>λ,而在BECs中,干扰素-λ>β>α。
我们得出结论,λ干扰素可能是BECs对呼吸道病毒固有反应期间产生的主要干扰素,PBMCs中产生的主要是α干扰素,而两种细胞类型均产生β干扰素。